Machine vision proposed for primary Pap screening
This article was originally published in Clinica
Executive Summary
NeoPath is for the second time asking the FDA to approve its AutoPap system as a fully automated primary screening device for cervical smears. If accepted, AutoPap could be used to screen out some slides as normal, so that they would not need to be examined by a cytologist.